EBOS Group (EBO.NZ) Stock Price

EBOS Group Price

NZX·CLOSED
18.29AUD+0.00 (+0.00 %)
Market closed

Over the last 19 years EBOS Group grew revenue by 22.3% annually, reaching 12.27 B AUD. Earnings per share have grown at 7.1% per year over the last 19 years. For EBOS Group, the net margin of 1.8% is broadly stable versus 2.0% a few years ago. At today's price the dividend yield works out to roughly 11.27%. The payout ratio is around 103% of earnings. The dividend has grown at 10.0% per year over the past 19 years. The consensus 12-month price target for EBOS Group is 31.61 AUD, about 72.8% above where the stock trades today. Of 13 analysts, 10 rate the stock a buy — an overall Buy consensus. The stock trades about 15% above its 52-week low.

EBOS Group stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of EBOS Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how EBOS Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing EBOS Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

EBOS Group Stock Price History
DateEBOS Group Price
7/24/202618.29 AUD
7/23/202618.24 AUD
7/22/202618.40 AUD
7/21/202618.50 AUD
7/20/202618.81 AUD
7/17/202618.92 AUD
7/16/202618.84 AUD
7/15/202618.79 AUD
7/14/202618.73 AUD
7/13/202618.48 AUD
7/9/202618.16 AUD
7/8/202617.83 AUD
7/7/202617.92 AUD
7/6/202617.69 AUD
7/3/202617.28 AUD
7/2/202616.84 AUD
7/1/202617.28 AUD
6/30/202617.05 AUD
6/29/202616.76 AUD
6/26/202616.90 AUD
6/25/202616.75 AUD
6/24/202616.44 AUD
6/23/202616.58 AUD
6/22/202616.78 AUD
6/19/202616.90 AUD
6/18/202616.62 AUD
6/17/202616.48 AUD
6/16/202616.76 AUD
6/15/202617.43 AUD
6/12/202617.74 AUD
6/11/202617.10 AUD
6/10/202617.20 AUD
6/9/202617.20 AUD
6/8/202616.87 AUD
6/5/202616.54 AUD
6/4/202616.11 AUD
6/3/202615.92 AUD
6/2/202616.41 AUD
5/29/202616.12 AUD
5/28/202615.90 AUD
5/27/202616.23 AUD
5/26/202616.16 AUD
5/25/202616.62 AUD
5/22/202616.63 AUD
5/21/202616.66 AUD
5/20/202616.54 AUD
5/19/202616.61 AUD
5/18/202616.54 AUD
5/15/202617.13 AUD
5/14/202616.98 AUD
5/13/202617.16 AUD
5/12/202617.06 AUD
5/11/202617.39 AUD
5/8/202617.50 AUD
5/7/202617.80 AUD
5/6/202617.40 AUD
5/5/202617.84 AUD
5/4/202617.53 AUD
5/1/202617.42 AUD
4/30/202617.41 AUD
4/29/202617.18 AUD
4/28/202617.17 AUD
4/24/202617.55 AUD
4/23/202617.36 AUD
4/22/202617.59 AUD
4/21/202618.21 AUD
4/20/202618.21 AUD
4/17/202618.13 AUD
4/16/202618.25 AUD
4/15/202618.70 AUD
4/14/202618.04 AUD
4/13/202618.08 AUD
4/10/202618.23 AUD
4/9/202618.62 AUD
4/8/202618.83 AUD
4/7/202619.11 AUD
4/2/202618.82 AUD
4/1/202617.97 AUD
3/31/202618.21 AUD
3/30/202617.85 AUD
3/27/202618.49 AUD
3/26/202618.00 AUD
3/25/202618.37 AUD
3/24/202617.59 AUD
3/23/202617.92 AUD
3/20/202617.89 AUD
3/19/202617.72 AUD
3/18/202618.25 AUD
3/17/202618.21 AUD
3/16/202618.53 AUD
3/13/202618.22 AUD
3/12/202618.21 AUD
3/11/202618.59 AUD
3/10/202618.53 AUD
3/9/202618.82 AUD
3/6/202618.82 AUD
3/5/202618.94 AUD
3/4/202619.37 AUD
3/3/202619.43 AUD
3/2/202619.16 AUD
2/27/202619.61 AUD
2/26/202619.64 AUD
2/25/202619.70 AUD
2/24/202619.64 AUD
2/23/202619.99 AUD
2/20/202619.97 AUD
2/19/202620.80 AUD
2/18/202620.21 AUD
2/17/202619.43 AUD
2/16/202619.78 AUD
2/13/202619.64 AUD
2/12/202620.36 AUD
2/11/202620.46 AUD
2/10/202621.11 AUD
2/9/202621.07 AUD
2/5/202620.96 AUD
2/4/202620.94 AUD
2/3/202620.86 AUD
2/2/202621.18 AUD
1/30/202621.04 AUD
1/29/202620.95 AUD
1/28/202621.28 AUD
1/27/202621.81 AUD
1/26/202622.00 AUD
1/23/202621.71 AUD
1/22/202621.64 AUD
1/21/202621.28 AUD
1/20/202621.44 AUD
1/19/202621.37 AUD
1/16/202621.65 AUD
1/15/202621.42 AUD
1/14/202621.60 AUD
1/13/202621.82 AUD
1/12/202622.46 AUD
1/9/202622.54 AUD
1/8/202622.50 AUD
1/7/202622.69 AUD
1/6/202622.62 AUD
1/5/202622.51 AUD
12/31/202522.60 AUD
12/30/202522.71 AUD
12/29/202522.61 AUD
12/24/202522.94 AUD
12/23/202522.90 AUD
12/22/202522.96 AUD
12/19/202522.53 AUD
12/18/202522.04 AUD
12/17/202521.98 AUD
12/16/202522.58 AUD
12/15/202522.63 AUD
12/12/202522.53 AUD
12/11/202522.30 AUD
12/10/202522.81 AUD
12/9/202522.45 AUD
12/8/202522.66 AUD
12/5/202522.99 AUD
12/4/202522.95 AUD
12/3/202523.32 AUD
12/2/202523.41 AUD
12/1/202523.18 AUD
11/28/202523.32 AUD
11/27/202522.87 AUD
11/26/202523.40 AUD
11/25/202523.23 AUD
11/24/202523.68 AUD
11/21/202523.84 AUD
11/20/202523.90 AUD
11/19/202523.84 AUD
11/18/202523.62 AUD
11/17/202524.10 AUD
11/14/202523.58 AUD
11/13/202523.43 AUD
11/12/202523.40 AUD
11/11/202523.08 AUD
11/10/202523.35 AUD
11/7/202523.49 AUD
11/6/202523.16 AUD
11/5/202523.53 AUD
11/4/202523.61 AUD
11/3/202523.62 AUD
10/31/202523.65 AUD
10/30/202523.68 AUD
10/29/202523.05 AUD
10/28/202522.91 AUD
10/24/202523.24 AUD
10/23/202523.08 AUD
10/22/202523.05 AUD
10/21/202523.16 AUD
10/20/202523.44 AUD
10/17/202523.49 AUD
10/16/202523.59 AUD
10/15/202524.20 AUD
10/14/202523.88 AUD
10/13/202523.88 AUD
10/10/202524.21 AUD
10/9/202524.31 AUD
10/8/202524.25 AUD
10/7/202524.02 AUD
10/6/202524.15 AUD
10/3/202524.57 AUD
10/2/202524.51 AUD
10/1/202524.59 AUD
9/30/202524.37 AUD
9/29/202524.22 AUD
9/26/202524.55 AUD
9/25/202523.89 AUD
9/24/202523.88 AUD
9/23/202524.17 AUD
9/22/202523.49 AUD
9/19/202524.43 AUD
9/18/202523.42 AUD
9/17/202523.61 AUD
9/16/202523.57 AUD
9/15/202523.61 AUD
9/12/202524.05 AUD
9/11/202523.98 AUD
9/10/202523.92 AUD
9/9/202524.52 AUD
9/8/202525.08 AUD
9/5/202525.24 AUD
9/4/202525.98 AUD
9/3/202526.51 AUD
9/2/202527.00 AUD
9/1/202527.23 AUD
8/29/202526.68 AUD
8/28/202526.64 AUD
8/27/202527.70 AUD
8/26/202532.16 AUD
8/25/202532.54 AUD
8/22/202532.77 AUD
8/21/202533.75 AUD
8/20/202532.94 AUD
8/19/202532.93 AUD
8/18/202532.90 AUD
8/15/202533.10 AUD
8/14/202533.21 AUD
8/13/202533.10 AUD
8/12/202533.04 AUD
8/11/202533.67 AUD
8/8/202533.53 AUD
8/7/202533.71 AUD
8/6/202533.61 AUD
8/5/202533.75 AUD
8/4/202532.77 AUD
8/1/202532.72 AUD
7/31/202533.47 AUD
7/30/202533.26 AUD
7/29/202533.33 AUD
7/28/202533.72 AUD
Access this data via the Eulerpool API
Get Free API Key

EBOS Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
9.20 B AUD
287.39 M AUD
185.30 M AUD
Jan 1, 2022
10.73 B AUD
345.23 M AUD
202.61 M AUD
Jan 1, 2023
12.24 B AUD
444.86 M AUD
253.37 M AUD
Jan 1, 2024
13.19 B AUD
482.53 M AUD
271.55 M AUD
Jan 1, 2025
12.27 B AUD
423.10 M AUD
215.14 M AUD
Jan 1, 2026 (e)
13.73 B AUD
482.99 M AUD
253.67 M AUD
Jan 1, 2027 (e)
14.42 B AUD
518.97 M AUD
275.26 M AUD
Jan 1, 2028 (e)
15.11 B AUD
556.55 M AUD
306.65 M AUD

EBOS Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 27, 2026, 7:49 AM
 
REVENUEB AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB AUD
EBITM AUD
EBIT MARGIN%
NET INCOMEM AUD
NET INCOME GROWTH%
DIV.AUD
DIV. GROWTH%
SHARESM
20132014201520162017201820192020202120222023202420252026e2027e2028e
1.465.215.856.436.846.996.938.779.2010.7312.2413.1912.2713.7314.4215.11
31.18256.9912.189.976.382.13-0.8026.484.9916.6514.007.78-7.0011.945.004.81
12.269.889.899.529.7711.2511.6310.4610.6911.4912.6412.3713.3513.3513.3513.35
0.180.520.580.610.670.790.810.920.981.231.551.631.641.831.922.02
45.00139.00163.00179.00189.00214.00225.00259.00287.00345.00444.00482.00423.00482.00518.00556.00
3.082.672.792.782.763.063.252.953.123.213.633.653.453.513.593.68
22.0083.00102.00115.00119.00137.00137.00162.00185.00202.00253.00271.00215.00253.00275.00306.00
4.76277.2722.8912.753.4815.13–18.2514.209.1925.257.11-20.6617.678.7011.27
0.210.480.290.370.030.400.390.430.041.101.422.172.061.351.621.95
-55.32128.57-39.5827.59-91.891,233.33-2.5010.26-90.702,650.0029.0952.82-5.07-34.4720.0020.37
53.40146.70149.67151.13151.77151.85153.32161.56163.71176.95190.60192.17197.36197.36197.36197.36
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales EBOS Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue EBOS Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare EBOS Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares EBOS Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against EBOS Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

EBOS Group stock margins

The EBOS Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of EBOS Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for EBOS Group.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
10.70 %
3.12 %
2.01 %
Jan 1, 2022
11.49 %
3.22 %
1.89 %
Jan 1, 2023
12.65 %
3.64 %
2.07 %
Jan 1, 2024
12.38 %
3.66 %
2.06 %
Jan 1, 2025
13.35 %
3.45 %
1.75 %
Jan 1, 2026 (e)
13.35 %
3.52 %
1.85 %
Jan 1, 2027 (e)
13.35 %
3.60 %
1.91 %
Jan 1, 2028 (e)
13.35 %
3.68 %
2.03 %

EBOS Group Stock Revenue, EBIT, Earnings per Share

The EBOS Group earnings per share therefore indicates how much revenue EBOS Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
56.21 AUD
1.76 AUD
1.13 AUD
Jan 1, 2022
60.66 AUD
1.95 AUD
1.15 AUD
Jan 1, 2023
64.20 AUD
2.33 AUD
1.33 AUD
Jan 1, 2024
68.63 AUD
2.51 AUD
1.41 AUD
Jan 1, 2025
62.15 AUD
2.14 AUD
1.09 AUD
Jan 1, 2026 (e)
69.57 AUD
2.45 AUD
1.29 AUD
Jan 1, 2027 (e)
73.05 AUD
2.63 AUD
1.39 AUD
Jan 1, 2028 (e)
76.56 AUD
2.82 AUD
1.55 AUD

EBOS Group business model & stock analysis

The EBOS Group was founded in New Zealand in 2000 and has since grown to become one of the largest healthcare companies in the region. The company's business model is to provide solutions for the healthcare industry, ranging from products for pharmacies, hospitals, and medical practices to healthcare services. The company is divided into several divisions, including healthcare distribution, dental, and healthcare services. The healthcare distribution division focuses on distributing pharmaceutical products, medical devices, and other healthcare items to healthcare facilities. This includes surgical instruments and oncology products. The dental division specializes in selling and distributing dental products, such as instruments for dentists and consumables like gloves, implants, and floss. They also offer services for dentists, including a dental practice built in partnership with another company. The healthcare services division includes the distribution of home care and healthcare products, as well as the rental of medical equipment like wheelchairs and beds. EBOS Group also provides services such as consultation and training for patients, caregivers, and healthcare providers. With a strong emphasis on quality and customer satisfaction, EBOS Group has a successful track record and has acquired and developed several companies in the region. Their products help improve patient health and contribute to reducing healthcare costs. The company plays a vital role in the healthcare products and services market. The EBOS Group's diverse divisions and wide range of products secure its position as an important player in the healthcare industry.

EBOS Group SWOT Analysis

Strengths

EBOS Group Ltd, a leading healthcare and animal care provider, holds several strengths that contribute to its success:

  • Strong market presence with a wide range of portfolio offerings.
  • Well-established distribution network enabling efficient delivery of products.
  • Strong financial performance and robust profitability.
  • Strong relationships with suppliers and customers.

Weaknesses

Despite its strengths, EBOS Group Ltd also faces certain weaknesses:

  • Relatively high dependency on a limited number of key suppliers.
  • Geographic concentration, making it vulnerable to regional economic and political instability.
  • Some product lines have faced pricing pressures and increased competition.
  • Higher operating costs due to regulatory compliance requirements.

Opportunities

EBOS Group Ltd can capitalize on the following opportunities in the market:

  • Increasing global demand for healthcare and animal care products.
  • Growing awareness and focus on preventive healthcare.
  • Expansion into emerging markets with untapped potential.
  • Potential for strategic partnerships or acquisitions to enhance the product portfolio.

Threats

However, EBOS Group Ltd also faces certain threats that could impact its performance:

  • Increase in regulatory compliance requirements, leading to higher costs.
  • Intense competition and price pressures in the healthcare and animal care sectors.
  • Fluctuating currency exchange rates impacting imports and exports.
  • Technological advancements requiring continuous investments in systems and infrastructure.

EBOS Group Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

EBOS Group historical P/E ratio, EBIT multiple, and P/S ratio

EBOS Group annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

EBOS Group shares outstanding

The number of shares of EBOS Group was 197.36 M in 2025. This indicates how many shares EBOS Group is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
163.71 M Stocks
Jan 1, 2022
176.95 M Stocks
Jan 1, 2023
190.60 M Stocks
Jan 1, 2024
192.17 M Stocks
Jan 1, 2025
197.36 M Stocks
Jan 1, 2026 (e)
197.36 M Stocks
Jan 1, 2027 (e)
197.36 M Stocks
Jan 1, 2028 (e)
197.36 M Stocks

EBOS Group stock splits

In EBOS Group's history, there have been no stock splits.

EBOS Group Dividend History

35 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.65AUDYTD—1×
Mar 5, 20260.65AUD↓ 7.3%1/1
20252.06AUD↓ 5.1%3×
Feb 27, 20250.65AUD↓ 20.7%1/3
Feb 28, 20250.71AUD↑ 9.1%2/3
Sep 4, 20250.70AUD↓ 1.1%3/3
20242.17AUD↑ 52.8%3×
20231.42AUD↑ 29.8%2×
20221.10AUD↑ 2,706.3%2×
20210.04AUD↓ 90.9%2×
20200.43AUD↑ 8.7%2×
20190.39AUD↓ 2.3%2×
20180.40AUD↑ 1,353.8%2×
20170.03AUD↓ 92.4%2×

EBOS Group dividend history and estimates

In 2025, EBOS Group paid a dividend amounting to 2.06 AUD. Dividend means that EBOS Group distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2021
0.04 AUD
0.00 AUD
0.00 AUD
Jan 1, 2022
1.10 AUD
0.00 AUD
0.00 AUD
Jan 1, 2023
1.42 AUD
0.00 AUD
0.00 AUD
Jan 1, 2024
2.17 AUD
0.00 AUD
0.00 AUD
Jan 1, 2025
2.06 AUD
0.00 AUD
0.00 AUD
Jan 1, 2026
1.35 AUD
0.00 AUD
0.00 AUD
Jan 1, 2027 (e)
0.00 AUD
1.62 AUD
0.00 AUD
Jan 1, 2028 (e)
0.00 AUD
1.95 AUD
0.00 AUD

EBOS Group dividend payout ratio

In 2025, EBOS Group had a payout ratio of 102.88%. The payout ratio indicates the percentage of the company's profits that EBOS Group distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
2.86 %
Jan 1, 2022
79.35 %
Jan 1, 2023
88.68 %
Jan 1, 2024
79.36 %
Jan 1, 2025
102.88 %
Jan 1, 2026 (e)
105.23 %
Jan 1, 2027 (e)
116.37 %
Jan 1, 2028 (e)
125.35 %

Current EBOS Group forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy84.62 % (11)
Hold7.69 % (1)
Sell7.69 % (1)
12M Price Target
0.00
Last Price
18.29
Currency
AUD
12M Return Potential
-100.00 %
LTM Return
0 %

EESG©

Eulerpool ESG Scorecard© for the EBOS Group stock

68/100
73
Environment
57
Social
73
Governance
E

Environment

20
Scope 1 - Direct Emissions3,530
Scope 2 - Indirect emissions from purchased energy18,289
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions21,820
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees56
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

EBOS Group shareholder structure

% Name
6.51302%
AustralianSuper
AustralianSuper
5.04549%
Sybos Holdings Pte. Ltd.
Sybos Holdings Pte. Ltd.
4.91007%
Harbour Asset Management Limited
Harbour Asset Management Limited
3.23831%
Accident Compensation Corporation
Accident Compensation Corporation
3.14883%
Capital Research Global Investors
Capital Research Global Investors
3.03578%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
...

EBOS Group Executives and Management Board

JC

Mr. John Matthew Cullity

Chief Executive Officer

Compensation6.65 M AUD
EC

Ms. Elizabeth Coutts

Independent Non-Executive Chairman of the Board

Compensation408,450.00 AUD
SM

Mr. Stuart McLauchlan

Non-Executive Independent Director

Compensation235,725.00 AUD
TB

Dr. Tracey Batten

(58)

Non-Executive Independent Director

Compensation193,725.00 AUD
MB

Mr. Mark Bloom

(66)

Non-Executive Independent Director

Compensation190,838.00 AUD

Frequently asked questions about EBOS Group

The business model of EBOS Group Ltd revolves around its position as a leading distributor of healthcare, laboratory, and pharmaceutical products. EBOS Group Ltd operates through two segments: Healthcare and Animal Care. The Healthcare segment supplies a broad range of medical products to public and private hospitals, pharmacies, and healthcare providers. The Animal Care segment focuses on providing veterinary products and services to veterinarians, farmers, and other animal healthcare professionals. With its robust distribution network and comprehensive product portfolio, EBOS Group Ltd strives to enhance healthcare outcomes and deliver value to its customers in the healthcare and animal care sectors.

All fundamentals and in-depth analysis of EBOS Group

Our stock analysis for EBOS Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of EBOS Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

EBOS Group Stock
EBOS Group Revenue→
EBOS Group Stock
EBOS Group Net Income→
EBOS Group Stock
EBOS Group P/E→
EBOS Group Stock
EBOS Group P/S→
EBOS Group Stock
EBOS Group EBIT→
EBOS Group Stock
EBOS Group Dividend→
EBOS Group Stock
EBOS Group Directors Dealings→
EBOS Group Stock
EBOS Group Stocks→
EBOS Group Stock
EBOS Group Market capitalization→
EBOS Group Stock
EBOS Group Debt→
EBOS Group Stock
EBOS Group Liabilities→
EBOS Group Stock
EBOS Group Equity→
EBOS Group Stock
EBOS Group AAQS→
EBOS Group Stock
EBOS Group Employees→
EBOS Group Stock
EBOS Group ROE→
EBOS Group Stock
EBOS Group ROA→
EBOS Group Stock
EBOS Group ROCE→
EBOS Group Stock
EBOS Group News→
EBOS Group Stock
EBOS Group Analyst Price Targets→

Health Stocks

ECGI HoldingsEBM TechnologiesEckert & ZieglerEasywell BiomedicalsEco Science SolutionsEastwood Bio-Medical CanadaECS Botanics HoldingsEarth Science TechEdan InstrumentsEagle Veterinary Technology CoEdap TmsEagle PharmaceuticalsAll Stocks A–Z →